The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Human AB Serum and Thrombin-Activated Platelet-Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue
Abstract
MSCs are currently in focus regarding their clinical potential in cell therapy and tissue engineering. However, most isolation and expansion protocols for clinical-scale production of MSCs use fetal calf serum (FCS) as a supplement, which poses a potential risk for infections as well as immunological reactions. To find a suitable FCS substitute, we investigated the effects of pooled human AB serum (AB-HS) and thrombin-activated platelet-rich plasma (tPRP) on adipose tissue MSCs (AT-MSCs) with FCS as the standard control medium. AT-MSCs of 10 donors were cultured under three different conditions: (a) 10% FCS, (b) 10% AB-HS, and (c) 10% tPRP. Colony-forming units, cumulative population doubling rates, and differentiation capacity toward the adipogenic and osteogenic lineages were assessed, along with immunophenotype. We demonstrated that AB-HS and tPRP provide a significantly higher proliferative effect on AT-MSCs than does FCS. In the first six passages, AB-HS and tPRP MSCs exhibited a fold expansion of 66.6 ± 15.7 and 68.1 ± 6.7, respectively, compared with 24.4 ± 0.7 for FCS. Differentiation capacity was preserved throughout long-term culture. Immunophenotype was characteristic for MSCs and comparable for all culture conditions with the exception of a distinct CD45-/CD14-positive side population for AB-HS and tPRP that tended to diminish with prolonged culture. We showed that pooled human AB serum and thrombin-activated platelet-rich plasma are alternatives to FCS for AT-MSCs. These human sources are better characterized regarding potential infectious threats, while providing a higher proliferation rate and retaining differentiation capacity and mesenchymal stem cell marker expression throughout long-term culture. Disclosure of potential conflicts of interest is found at the end of this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370
Self-citationLe Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Platelet-rich plasma: evidence to support its use
Marx, R. E. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2003.12.003 · Cited by 1,942
Chen, S.-L., Fang, W.-W., Ye, F., Liu, Y.-H., Qian, J., Shan, S.-J., Zhang, J.-J., Chunhua, R. Z., Liao, L.-M., Lin, S., et al. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.034 · Cited by 1,191
Koç, O. N., Gerson, S. L., Cooper, B. W., Dyhouse, S. M., Haynesworth, S. E., Caplan, A. I., & Lazarus, H. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.307 · Cited by 1,119
Baksh, D., Song, L., & Tuan, R. S. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00320.x · Cited by 1,105
Autologous mesenchymal stem cell transplantation in stroke patients
Bang, O. Y., Lee, J. S., Lee, P. H., & Lee, G. (2005) · Annals of Neurology · doi:10.1002/ana.20501 · Cited by 1,102
Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood
Bieback, K., Kern, S., Klüter, H., & Eichler, H. (2004) · Stem Cells · doi:10.1634/stemcells.22-4-625 · Cited by 931
Self-citationIn vitro Hepatic Differentiation of Human Mesenchymal Stem Cells
Lee, K., Kuo, T. K., Whang–Peng, J., Chung, Y., Lin, C., Chou, S., Chen, J., Chen, Y., & Lee, O. K. (2004) · Hepatology · doi:10.1002/hep.20469 · Cited by 865
Yoshimura, K., Shigeura, T., Matsumoto, D., Sato, T., Takaki, Y., Aiba‐Kojima, E., Sato, K., Inoue, K., Nagase, T., Koshima, I., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20636 · Cited by 803
Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood Platelets
GAARDER, A., JONSEN, J., LALAND, S., HELLEM, A., & OWREN, P. A. (1961) · Nature · doi:10.1038/192531a0 · Cited by 786
Doucet, C., Ernou, I., Zhang, Y., Llense, J.-R., Begot, L., Holy, X., & Lataillade, J.-J. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20391 · Cited by 689
Sotiropoulou, P. A., Perez, S. A., Salagianni, M., Baxevanis, C. N., & Papamichail, M. (2006) · Stem Cells · doi:10.1634/stemcells.2004-0331 · Cited by 627
Spees, J. L., Gregory, C. A., Singh, H., Tucker, H. A., Peister, A., Lynch, P. J., Hsu, S.-C., Smith, J., & Prockop, D. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.02.012 · Cited by 509
Shahdadfar, A., Frønsdal, K., Haug, T., Reinholt, F. P., & Brinchmann, J. E. (2005) · STEM CELLS · doi:10.1634/stemcells.2005-0094 · Cited by 501
Gronthos, S., & Simmons, P. (1995) · Blood · doi:10.1182/blood.v85.4.929.bloodjournal854929 · Cited by 342
Factors required for bone marrow stromal fibroblast colony formation in vitro
Kuznetsov, S. A., Friedenstein, A. J., & Gehron Robey, P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.902904.x · Cited by 277
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use
Stute, N., Holtz, K., Bubenheim, M., Lange, C., Blake, F., & Zander, A. R. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.09.003 · Cited by 275
Selvaggi, T. A., Walker, R. E., & Fleisher, T. A. (1997) · Blood · doi:10.1182/blood.v89.3.776 · Cited by 272
Tamama, K., Fan, V. H., Griffith, L. G., Blair, H. C., & Wells, A. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0176 · Cited by 256
Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans
Mazzini, L., Fagioli, F., Boccaletti, R., Mareschi, K., Oliveri, G., Olivieri, C., Pastore, I., Marasso, R., & Madon, E. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310014653 · Cited by 256
Mesenchymal Stem Cells: Cell Biology and Potential Use in Therapy
Kassem, M., Kristiansen, M., & Abdallah, B. M. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.pto950502.x · Cited by 241
Gruber, R., Varga, F., Fischer, M. B., et al. (2002) · Clinical Oral Implants Research · doi:10.1034/j.1600-0501.2002.130513.x · Cited by 240
Marrow Stromal Cells, Mitosis, and Neuronal Differentiation: Stem Cell and Precursor Functions
Muñoz‐Elías, G., Woodbury, D., & Black, I. B. (2003) · STEM CELLS · doi:10.1634/stemcells.21-4-437 · Cited by 211
Senger, D. R., Perruzzi, C. A., Papadopoulos-Sergiou, A., & Van de Water, L. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.5.565 · Cited by 208
Gruber, R., Karreth, F., Kandler, B., Fuerst, G., Rot, A., Fischer, M. B., & Watzek, G. (2004) · Platelets · doi:10.1080/09537100310001643999 · Cited by 185
Tuschong, L., Soenen, S. L., Blaese, R. M., Candotti, F., & Muul, L. M. (2002) · Human Gene Therapy · doi:10.1089/10430340260201699 · Cited by 173
Chen, S., Wu-wang, F., Qian, J., et al. (2004) · PubMed · Cited by 163
Kilián, O., Flesch, I., Wenisch, S., Taborski, B., Jork, A., Schnettler, R., & Jonuleit, T. (2004) · PubMed · Cited by 141
Mechanisms of Cellular Activation by Platelet Microparticles
Barry, Ó. P., & FitzGerald, G. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615913 · Cited by 132
Cell Culture Medium Composition and Translational Adult Bone Marrow‐Derived Stem Cell Research
Sotiropoulou, P. A., Perez, S. A., Salagianni, M. L., Baxevanis, C. N., & Papamichail, M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0654 · Cited by 96
In Vitro Control of Human Bone Marrow Stromal Cells for Bone Tissue Engineering
Anselme, K., Broux, O., Noel, B., Bouxin, B., Bascoulergue, G., Dudermel, A.-F., Bianchi, F., Jeanfils, J., & Hardouin, P. (2002) · Tissue Engineering · doi:10.1089/107632702320934047 · Cited by 75
Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion
Yamaguchi, M., Hirayama, F., Wakamoto, S., Fujihara, M., Murahashi, H., Sato, N., Ikebuchi, K., Sawada, K., Koike, T., Kuwabara, M., et al. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00149.x · Cited by 69
Fully automated processing of buffy‐coat–derived pooled platelet concentrates
Janetzko, K., Klüter, H., van Waeg, G., & Eichler, H. (2004) · Transfusion · doi:10.1111/j.1537-2995.2004.03296.x · Cited by 33
Self-citationForeman, M. A., Smith, J., & Publicover, S. J. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20521 · Cited by 32
Cited by
Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?
Burnouf, T., Strunk, D., Koh, M. B. C., & Schallmoser, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.065 · Cited by 521
Fetal Bovine Serum (FBS): past ‐ present ‐ future
van der Valk, J. (2018) · ALTEX · doi:10.14573/altex.1705101 · Cited by 481
The Potential of Adipose Stem Cells in Regenerative Medicine
Lindroos, B., Suuronen, R., & Miettinen, S. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9193-7 · Cited by 441
Zhu, Y., Yuan, M., Meng, H. Y., Wang, A. Y., Guo, Q. Y., Wang, Y., & Peng, J. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.07.017 · Cited by 366
Kim, D. H., Je, Y. J., Kim, C. D., Lee, Y. H., Seo, Y. J., Lee, J. H., & Lee, Y. (2011) · Annals of Dermatology · doi:10.5021/ad.2011.23.4.424 · Cited by 349
Metadata
- Authors
- Kocaoemer, A., Kern, S., Klüter, H., & Bieback, K.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-25
- Volume
- 25
- Issue
- 5
- Pages
- 1270-1278
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2053976497
- Cited by
- 414
- References
- 38
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.